Ratiopharm GmbH submitted applications for mutual recognition of Fentanyl-ratiopharm 25/ 50/ 75/ 100 µg/ h Matrixpflaster and associated names, transdermal patch on the basis of the marketing authorisation granted by Germany 04 April 2006.